Ian G. Armitage,Reenu Chopra,Martin Ian Cooper,Marianne Langston,Steven P. Langston,Stepan Vyskocil
申请号：
US14879151
公开号：
US20160030432A1
申请日:
2015.10.09
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Disclosed is a compound of formula (I):crystalline forms thereof, and solvates thereof； pharmaceutical compositions comprising a pharmaceutically effective amount of the compound of formula (I), or a crystalline form thereof, or a solvate thereof, and a pharmaceutically acceptable carrier or diluent； and the use of a compound of formula (I), or a crystalline form thereof, or a solvate thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting an E1 activating enzyme, particularly NAE, including, e.g., cancer.
